Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System
“XIENCE V showed statistically significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”.
Related post here
Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System
“XIENCE V showed statistically significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”.
Related post here
Follow @sibaya_com on Twitter
Looking cardiac interventional product for distributorship in bangladesh.
I want to know what is your companys terms& condition for distributor in bangladesh.